13F Data
13F filer · CIK 1807489

M28 Capital Management LP

STAMFORD, CT · filing since Q4 2021 · last filing Aug 13, 2026
Reported value
$47.2M
$-6.6M vs prior
Positions
9
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $128.1MQ1 2022: $108.8MQ2 2022: $89.2MQ3 2022: $95.8MQ4 2022: $104.9MQ1 2023: $88.4MQ2 2023: $75.7MQ3 2023: $87.2MQ4 2023: $120.7MQ1 2024: $135.3MQ2 2024: $77.1MQ3 2024: $91.0MQ4 2024: $101.9MQ1 2025: $73.0MQ2 2025: $58.6MQ3 2025: $68.0MQ4 2025: $137.6MQ1 2026: $53.8MQ2 2026: $47.2M
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1WAVE LIFE SCIENCES LTDSHS4,588,284$26.7M56.53%
2INVIVYD INCCOM9,248,250$8.1M17.11%
3TG THERAPEUTICS INCCOM88,354$4.9M10.29%
4ARROWHEAD PHARMACEUTICALS INCOM36,851$3.0M6.37%
5FRACTYL HEALTH INCCOM1,856,117$1.5M3.13%
6PROQR THRAPEUTICS N VSHS EURO599,793$1.1M2.37%
7SILENCE THERAPEUTICS PLCADS101,203$1.1M2.36%
8ROCKET PHARMACEUTICALS INCCOM210,871$721.2K1.53%
9CURIS INCCOM284,889$148.7K0.32%